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Compendium of Animal Rabies Prevention and Control, 2004*
National Association of State Public Health Veterinarians, Inc. (NASPHV)
Rabies is a fatal viral zoonosis and a serious public health problem (1). The purpose of this compendium is to provide information to
veterinarians, public health officials, and others concerned with rabies prevention and control. These recommendations serve as the basis
for animal rabies-control programs throughout the United States and facilitate standardization of procedures among jurisdictions,
thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary.
Parenteral vaccination procedure recommendations are contained in Part I; Part II details the principles of rabies control; all animal




A. Vaccine Administration. All animal rabies vaccines should
be restricted to use by or under the direct supervision of a
veterinarian (2), except as recommended in Part II.B.1.
All vaccines must be administered in accordance with the
specifications of the product label or package insert.
B. Vaccine Selection. Part III lists all vaccines licensed by
USDA and marketed in the United States at the time of
publication. New vaccine approvals or changes in label
specifications made subsequent to publication should be
considered as part of this list. Any of the listed vaccines
can be used for revaccination, even if the product is not
the same brand as previously administered vaccines. Vac-
cines used in state and local rabies control programs should
have a 3-year duration of immunity. This constitutes the
most effective method of increasing the proportion of
immunized dogs and cats in any population (3). No labo-
ratory or epidemiologic data exist to support the annual or
biennial administration of 3-year vaccines following the
initial series.
C. Adverse Events. Currently, no epidemiologic association
exists between a particular licensed vaccine product and
adverse events including vaccine failure (4,5). Adverse
events should be reported to the vaccine manufacturer and
to USDA, Animal and Plant Health Inspection Service,
Center for Veterinary Biologics (Internet: http://www.
aphis.usda.gov/vs/cvb/ic/adverseeventreport.htm; tele-
phone: 800-752-6255; or e-mail: CVB@usda.gov).
D. Wildlife and Hybrid Animal Vaccination. The efficacy
of parenteral rabies vaccination of wildlife and hybrids (the
offspring of wild animals crossbred to domestic animals)
has not been established, and no such vaccine is licensed
for these animals. Zoos or research institutions may estab-
lish vaccination programs, which attempt to protect valu-
able animals, but these should not replace appropriate
public health activities that protect humans.
E. Accidental Human Exposure to Vaccine. Human expo-
sure to parenteral animal rabies vaccines listed in Part III
does not constitute a risk for rabies infection. However,
human exposure to vaccinia-vectored oral rabies vaccines
should be reported to state health officials (6).
F. Rabies Certificate. All agencies and veterinarians should
use the NASPHV Form 51, “Rabies Vaccination Certifi-
cate,” which can be obtained from vaccine manufacturers.
The form must be fully completed and signed by the
administering or supervising veterinarian. This form can
also be found on the CDC Internet site (http://www.
cdc.gov/ncidod/dvrd/rabies/professional/professi.htm).
Computer-generated forms containing the same information
are acceptable.
Part II: Rabies Control
A. Principles of Rabies Control.
1. Rabies Exposure. Rabies is transmitted only when the
virus is introduced into bite wounds, open cuts in skin,
or onto mucous membranes (7).
2. Human Rabies Prevention. Rabies in humans can be
prevented either by eliminating exposures to rabid
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animals or by providing exposed persons with prompt lo-
cal treatment of wounds combined with the administra-
tion of human rabies immune globulin and vaccine. The
rationale for recommending preexposure and postexposure
rabies prophylaxis and details of their administration can
be found in the current recommendations of the Advisory
Committee on Immunization Practices (ACIP) (7). These
recommendations, with information concerning the cur-
rent local and regional status of animal rabies and the avail-
ability of human rabies biologics, are available from state
health departments.
3. Domestic Animals. Local governments should initiate
and maintain effective programs to ensure vaccination
of all dogs, cats, and ferrets and to remove strays and
unwanted animals. Such procedures in the United States
have reduced laboratory-confirmed cases of rabies in
dogs from 6,949 in 1947 to 99 in 2002 (8). Because
more rabies cases are reported annually involving cats
(299 in 2002) than dogs, vaccination of cats should be
required. Animal shelters and animal control authori-
ties should establish policies to ensure that adopted
animals are vaccinated against rabies. The recommended
vaccination procedures and the licensed animal vaccines
are specified in Parts I and III of the compendium.
4. Rabies in Vaccinated Animals. Rabies is rare in vacci-
nated animals. If such an event is suspected, it should
be reported to state public health officials, the vaccine
manufacturer, and to USDA, Animal and Plant Health
Inspection Service, Center for Veterinary Biologics
(Internet: http://www.aphis.usda.gov/vs/cvb/ic/adverse
eventreport.htm; telephone: 800-752-6255; or e-mail:
CVB@usda.gov). The laboratory diagnosis should be
confirmed and the virus characterized by a rabies refer-
ence laboratory. A thorough epidemiologic investiga-
tion should be conducted.
5. Rabies in Wildlife. The control of rabies among wild-
life reservoirs is difficult (9). Vaccination of free-
ranging wildlife or selective population reduction might
be useful in some situations, but the success of such
procedures depends on the circumstances surrounding
each rabies outbreak (see Part C. Prevention and Con-
trol Methods Related to Wildlife). Because of the risk
of rabies in wild animals (especially raccoons, skunks,
coyotes, foxes, and bats), AVMA, NASPHV, and CSTE
strongly recommend the enactment of state laws pro-
hibiting their importation, distribution, and relocation.
6. Rabies Surveillance. Laboratory-based rabies surveil-
lance is an essential component of rabies control and
prevention programs. Accurate and timely information
is necessary to guide human postexposure prophylaxis
decisions; determine the management of potentially
exposed animals; aid in emerging pathogen discovery;
describe the epidemiology of the disease; and assess the
need for and effectiveness of oral vaccination programs
for wildlife.
7. Rabies Diagnosis. Rabies testing should be done by a
qualified laboratory, designated by the local or state health
department (10) in accordance with the established
national standardized protocol for rabies testing (http://
www.cdc.gov/ncidod/dvrd/rabies/Professional/publica-
tions/DFA_diagnosis/DFA_protocol-b.htm). Euthana-
sia (11) should be accomplished in such a way as to
maintain the integrity of the brain so that the laboratory
can recognize the anatomical parts. Except in the case of
very small animals (e.g., bats), only the head or brain
(including brain stem) should be submitted to the labo-
ratory. Any animal or animal part being submitted for
testing should be kept under refrigeration (not frozen or
chemically fixed) during storage and shipping.
8. Rabies Serology. Some “rabies-free” jurisdictions may
require evidence of vaccination and rabies antibodies
for importation purposes. Rabies antibody titers are
indicative of an animal’s response to vaccine or infec-
tion; titers are not indicators of protection. Other im-
munologic factors also play a role in preventing rabies,
and our abilities to measure and interpret those other
factors are not well-developed. Therefore, evidence of
circulating rabies virus antibodies should not be used
as a substitute for current vaccination in managing
rabies exposures or determining the need for booster
vaccinations (12).
B. Control Methods in Domestic and Confined Animals.
1. Preexposure Vaccination and Management. Parenteral
animal rabies vaccines should be administered only by
or under the direct supervision of a veterinarian.
Rabies vaccinations may also be administered under the
supervision of a veterinarian to animals held in animal
control shelters before release. Any veterinarian signing
a rabies certificate should ensure that the person
administering vaccine is identified on the certificate and
is appropriately trained in vaccine storage, handling,
administration, management of adverse events, etc. This
practice ensures that a qualified and responsible person
can be held accountable to ensure that the animal has
been properly vaccinated.
Within 28 days after primary vaccination, a peak
rabies antibody titer is reached, and the animal can be
considered immunized. An animal is currently vacci-
nated and is considered immunized if the primary vac-
cination was administered at least 28 days previously
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and vaccinations have been administered in accordance
with this compendium.
Regardless of the age of the animal at initial vaccina-
tion, a booster vaccination should be administered 1 year
later (see Parts I and III for vaccines and procedures). No
laboratory or epidemiologic data exist to support the
annual or biennial administration of 3-year vaccines fol-
lowing the initial series. Because a rapid anamnestic re-
sponse is expected, an animal is considered currently
vaccinated immediately after a booster vaccination.
a. Dogs, Cats, and Ferrets. All dogs, cats, and ferrets
should be vaccinated against rabies and revaccinated
in accordance with Part III of this compendium. If
a previously vaccinated animal is overdue for a
booster, it should be revaccinated with a single dose
of vaccine. Immediately following the booster, the
animal is considered currently vaccinated and should
be placed on an annual or triennial schedule depend-
ing on the type of vaccine used.
b. Livestock. Consideration should be given to vacci-
nating livestock that are particularly valuable or that
might have frequent contact with humans (e.g., in
petting zoos, fairs, and other public exhibitions; see
http://www.avma.org/pubhlth/comp_animals_
public_settings.asp). Horses traveling interstate
should be currently vaccinated against rabies.
c. Confined Animals.
1) Wild. No parenteral rabies vaccines are licensed
for use in wild animals. Wild animals or hybrids
should not be kept as pets (13–16).
2) Maintained in Exhibits and in Zoological Parks.
Captive mammals that are not completely excluded
from all contact with rabies vectors can become
infected. Moreover, wild animals might be incu-
bating rabies when initially captured; therefore,
wild-caught animals susceptible to rabies should
be quarantined for a minimum of 6 months
before being exhibited. Employees who work with
animals at such facilities should receive preexposure
rabies vaccination. The use of pre- or postexposure
rabies vaccinations for employees who work with
animals at such facilities might reduce the need
for euthanasia of captive animals. Carnivores and
bats should be housed in a manner that precludes
direct contact with the public.
2. Stray Animals. Stray dogs, cats, and ferrets should be
removed from the community. Local health departments
and animal control officials can enforce the removal of
strays more effectively if owned animals are confined or
kept on leash. Strays should be impounded for >3 days
to determine if human exposure has occurred and to
give owners sufficient time to reclaim animals.
3. Importation and Interstate Movement of Animals.
a. International. CDC regulates the importation of
dogs and cats into the United States. Importers of
dogs must comply with rabies vaccination require-
ments (42 CFR, Part 71.51[c]) and complete CDC
form 75.37. The appropriate health official of the
state of destination should be notified within 72
hours of the arrival into his or her jurisdiction of
any imported dog required to be placed in confine-
ment under the CDC regulation. Failure to comply
with these requirements should be promptly reported
to the Division of Global Migration and Quaran-
tine, CDC (404-498-1670; http://www.cdc.gov/
ncidod/dq/lawsand.htm).
Federal regulations alone are insufficient to pre-
vent the introduction of rabid animals into the coun-
try (17,18). All imported dogs and cats are subject
to state and local laws governing rabies and should
be currently vaccinated against rabies in accordance
with this compendium. Failure to comply with state
or local requirements should be referred to the
appropriate state or local official.
b. Interstate. Before interstate movement, dogs, cats,
ferrets, and horses should be currently vaccinated
against rabies in accordance with the compendium’s
recommendations (see Part II.B.1. Preexposure Vac-
cination and Management). Animals in transit should
be accompanied by a currently valid NASPHV Form
51, Rabies Vaccination Certificate. When an inter-
state health certificate or certificate of veterinary
inspection is required, it should contain the same
rabies vaccination information as Form 51.
4. Adjunct Procedures. Methods or procedures that
enhance rabies control include the following:
a. Identification. Dogs, cats, and ferrets should be
identified (e.g., metal or plastic tags or microchips)
to allow for verification of rabies vaccination status.
b. Licensure. Registration or licensure of all dogs, cats,
and ferrets may be used to aid in rabies control. A
fee is frequently charged for such licensure, and rev-
enues collected are used to maintain rabies- or ani-
mal-control programs. Vaccination is an essential
prerequisite to licensure.
c. Canvassing of Area. House-to-house canvassing by
animal control officials facilitates enforcement of vac-
cination and licensure requirements.
d. Citations. Citations are legal summonses issued to
owners for violations, including failure to vaccinate
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or license their animals. The authority for officers
to issue citations should be an integral part of each
animal-control program.
e. Animal Control. All communities should incorpo-
rate stray animal control, leash laws, and training of
personnel in their programs.
5. Postexposure Management. Any animal potentially
exposed to rabies virus (see Part II.A.1. Rabies Expo-
sure) by a wild, carnivorous mammal or a bat that is
not available for testing should be regarded as having
been exposed to rabies.
a. Dogs, Cats, and Ferrets. Unvaccinated dogs, cats,
and ferrets exposed to a rabid animal should be
euthanized immediately. If the owner is unwilling
to have this done, the animal should be placed in
strict isolation for 6 months and vaccinated 1 month
before being released. Animals with expired vacci-
nations need to be evaluated on a case-by-case basis.
Protocols for the postexposure vaccination of previ-
ously unvaccinated domestic animals have not been
validated, and evidence exists that use of vaccine
alone will not prevent the disease (19). Dogs, cats,
and ferrets that are currently vaccinated should be
revaccinated immediately, kept under the owner’s
control, and observed for 45 days.
b. Livestock. All species of livestock are susceptible to
rabies; cattle and horses are among the most fre-
quently infected. Livestock exposed to a rabid ani-
mal and currently vaccinated with a vaccine approved
by USDA for that species should be revaccinated
immediately and observed for 45 days. Unvaccinated
livestock should be slaughtered immediately. If the
owner is unwilling to have this done, the animal
should be kept under close observation for 6 months.
The following are recommendations for owners of
unvaccinated livestock exposed to rabid animals:
1) If the animal is slaughtered within 7 days of
being bitten, its tissues may be eaten without risk
of infection, provided that liberal portions of the
exposed area are discarded. Federal guidelines for
meat inspectors require that any animal known
to have been exposed to rabies within 8 months
be rejected for slaughter.
2) Neither tissues nor milk from a rabid animal
should be used for human or animal consump-
tion (20). Pasteurization temperatures will inac-
tivate rabies virus; therefore, drinking pasteurized
milk or eating cooked meat does not constitute a
rabies exposure.
3) Having more than one rabid animal in a herd or
having herbivore-to-herbivore transmission is
uncommon; therefore, restricting the rest of the
herd if a single animal has been exposed to or
infected by rabies might not be necessary.
c. Other Animals. Other mammals bitten by a rabid
animal should be euthanized immediately. Animals
maintained in USDA-licensed research facilities or
accredited zoological parks should be evaluated on a
case-by-case basis.
6. Management of Animals That Bite Humans.
a. Dogs, Cats, and Ferrets. Rabies virus may be
excreted in the saliva of infected dogs, cats, and fer-
rets during illness and/or for only a few days before
illness or death (21–23). A healthy dog, cat, or fer-
ret that bites a person should be confined and
observed daily for 10 days; administration of rabies
vaccine is not recommended during the observation
period. Such animals should be evaluated by a vet-
erinarian at the first sign of illness during confine-
ment. Any illness in the animal should be reported
immediately to the local health department. If signs
suggestive of rabies develop, the animal should be
euthanized and the head shipped for testing as
described in Part II.A.7. Any stray or unwanted dog,
cat, or ferret that bites a person may be euthanized
immediately and the head submitted for rabies
examination.
b. Other Biting Animals. Other biting animals that
might have exposed a person to rabies should be
reported immediately to the local health department.
Prior vaccination of an animal may not preclude the
necessity for euthanasia and testing if the period of
virus shedding is unknown for that species. Man-
agement of animals other than dogs, cats, and fer-
rets depends on the species, the circumstances of the
bite, the epidemiology of rabies in the area, the bit-
ing animal’s history, current health status, and
potential for exposure to rabies.
C. Prevention and Control Methods Related to Wildlife.
The public should be warned not to handle or feed wild
mammals. Wild mammals and hybrids that bite or other-
wise expose persons, pets, or livestock should be consid-
ered for euthanasia and rabies examination. A person bitten
by any wild mammal should immediately report the inci-
dent to a physician who can evaluate the need for antira-
bies treatment (see current rabies prophylaxis
recommendations of the ACIP [7]). State regulated wild-
life rehabilitators may play a role in a comprehensive
rabies control program. Minimum standards for persons
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who rehabilitate wild mammals should include rabies vac-
cination, appropriate training and continuing education.
Translocation of infected wildlife has contributed to the
spread of rabies (24,25); therefore, the translocation of
known terrestrial rabies reservoir species should be
prohibited.
1. Terrestrial Mammals. The use of licensed oral vaccines
for the mass vaccination of free-ranging wildlife should
be considered in selected situations, with the approval
of the state agency responsible for animal rabies control
(9). The distribution of oral rabies vaccine should be
based on scientific assessments of the target species and
followed by timely and appropriate analysis of surveil-
lance data; such results should be provided to all stake-
holders. Continuous and persistent programs for
trapping or poisoning wildlife are not effective in
reducing wildlife rabies reservoirs on a statewide basis.
However, limited control in high-contact areas (e.g.,
picnic grounds, camps, or suburban areas) may be
indicated for the removal of selected high-risk species
of wildlife (9). State agriculture, public health, and wild-
life agencies should be consulted for planning, coordi-
nation, and evaluation of vaccination or population-
reduction programs.
2. Bats. Indigenous rabid bats have been reported from
every state except Hawaii, and have caused rabies in at
least 40 humans in the United States (26–29). Bats
should be excluded from houses, public buildings, and
adjacent structures to prevent direct association with
humans (30,31). Such structures should then be made
bat-proof by sealing entrances used by bats. Control-
ling rabies in bats through programs designed to
reduce bat populations is neither feasible nor desirable.
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PART III: Rabies vaccines licensed and marketed in the United States, 2004
For Dosage Age at primary Booster Route of
Product name Produced by Marketed by use in (mL) vaccination* recommended inoculation
A) MONOVALENT (Inactivated)
DEFENSOR 1 Pfizer, Inc. Pfizer, Inc. Dogs 1 3 mos† Annually IM§ or SC¶
   License No. 189 Cats 1 3 mos Annually SC
DEFENSOR 3 Pfizer, Inc. Pfizer, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 189 Cats 1 3 mos 1 year later and triennially SC
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABDOMUN 1 Pfizer, Inc. Schering-Plough Dogs 1 3 mos Annually IM or SC
   License No. 189 Cats 1 3 mos Annually SC
RABDOMUN Pfizer, Inc. Schering-Plough Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 189 Cats 1 3 mos 1 year later and triennially SC
Sheep 2 3 mos Annually IM
Cattle 2 3 mos Annually IM
RABVAC 1 Fort Dodge Animal Health Fort Dodge Animal Dogs 1 3 mos Annually IM or SC
   License No. 112    Health Cats 1 3 mos Annually IM or SC
RABVAC 3 Fort Dodge Animal Health Fort Dodge Animal Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 112    Health Cats 1 3 mos 1 year later and triennially IM or SC
Horses 2 3 mos Annually IM
RABVAC 3 TF Fort Dodge Animal Health Fort Dodge Animal Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 112    Health Cats 1 3 mos 1 year later and triennially IM or SC
Horses 2 3 mos Annually IM
PRORAB-1 Intervet, Inc. Intervet, Inc. Dogs 1 3 mos Annually IM or SC
   License No. 286 Cats 1 3 mos Annually IM or SC
Ferrets 1 3 mos Annually SC
Sheep 2 3 mos Annually IM
PRORAB-3F Intervet, Inc. Intervet, Inc. Cats 1 3 mos 1 year later and triennially IM or SC
   License No. 286
IMRAB 3 Merial, Inc. Merial, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 298 Cats 1 3 mos 1 year later and triennially IM or SC
Sheep 2 3 mos 1 year later and triennially IM or SC
Cattle 2 3 mos Annually IM or SC
Horses 2 3 mos Annually IM or SC
Ferrets 1 3 mos Annually SC
IMRAB 3 TF Merial, Inc. Merial, Inc. Dogs 1 3 mos 1 year later and triennially IM or SC
   License No. 298 Cats 1 3 mos 1 year later and triennially IM or SC
Ferrets 1 3 mos Annually SC
IMRAB Merial, Inc. Merial, Inc. Cattle 2 3 mos Annually IM or SC
Large Animal    License No. 298 Horses 2 3 mos Annually IM or SC
Sheep 2 3 mos 1 year later and triennially IM or SC
IMRAB 1 Merial, Inc. Merial, Inc. Dogs 1 3 mos Annually SC
   License No. 298 Cats 1 3 mos Annually SC
B) MONOVALENT (Rabies glycoprotein, live canary pox vector)
PUREVAX Feline Merial, Inc. Merial, Inc. Cats 1 2 mos Annually SC
   Rabies    License No. 298
C) COMBINATION (Inactivated rabies)
ECLIPSE 3 + Fort Dodge Animal Health Schering-Plough Cats 1 3 mos Annually IM or SC
   FeLV/R    License No. 112
ECLIPSE 4 + Fort Dodge Animal Health Schering-Plough Cats 1 3 mos Annually IM or SC
   FeLV/R    License No. 112
Fel-O-Guard 3 + Fort Dodge Animal Health Fort Dodge Animal Cats 1 3 mos Annually IM or SC
   FeLV/R    License No. 112    Health
Fel-O-Guard 4 + Fort Dodge Animal Health Fort Dodge Animal Cats 1 3 mos Annually IM or SC
   FeLV/R    License No. 112    Health
IMRAB 3 + Feline 3 Merial, Inc. Merial, Inc. Cats 1 3 mos 1 year later and triennially SC
   License No. 298
IMRAB 3 + Feline 4 Merial, Inc. Merial, Inc. Cats 1 3 mos 1 year later and triennially SC
   License No. 298
Equine POTOMAVAC Merial, Inc. Merial, Inc. Horses 1 3 mos Annually IM
   + IMRAB    License No. 298
MYSTIQUE II Intervet, Inc. Intervet, Inc. Horses 1 3 mos Annually IM
   POTOMAVAC +    License No. 286
D) COMBINATION  (Rabies glycoprotein, live canary pox vector)
PUREVAX Feline Merial, Inc. Merial, Inc. Cats 1 8 wks Annually SC
   3/Rabies    License No. 298
PUREVAX Feline Merial, Inc. Merial, Inc. Cats 1 8 wks Annually SC
   4/Rabies    License No. 298
PUREVAX Feline Merial, Inc. Merial, Inc. Cats 1 8 wks Annually SC
   3/Rabies + LEUCAT    License No. 298
PUREVAX Feline Merial, Inc. Merial, Inc. Cats 1 8 wks Annually SC
   4/Rabies + LEUCAT    License No. 298
E) ORAL (Rabies glycoprotein, live vaccinia vector) - RESTRICTED TO USE IN STATE AND FEDERAL RABIES-CONTROL PROGRAMS
RABORAL V-RG Merial, Inc. Merial, Inc. Raccoons N/A N/A As determined by local Oral
   License No. 298 Coyotes    authorities
* Minimum age (or older) and revaccinated 1 year later.
† 1 month = 28 days.
§ Intramuscularly.
¶ Subcutaneously.
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This report summarizes West Nile virus (WNV) surveillance
data reported to CDC through ArboNET and by states and
other jurisdictions as of August 7, 2002.
United States
During the reporting period of July 31–August 7, a total of
68 laboratory-positive human cases of WNV-associated ill-
ness were reported from Louisiana (n=40), Mississippi (n=23),
Texas (n=four), and Illinois (n=one). During the same
period, WNV infections were reported in 447 dead crows,
263 other dead birds, 42 horses, and 183 mosquito pools.
During 2002, a total of 112 human cases with laboratory
evidence of recent WNV infection have been reported from
Louisiana (n=71), Mississippi (n=28), Texas (n=12), and Illi-
nois (n=one). Five deaths have been reported, all from Louisi-
ana. Among the 98 cases with available data, 59 (60%)
occurred among men; the median age was 55 years (range:
3–88 years), and the dates of illness onset ranged from June 10
to July 29.In addition, 1,076 dead crows and 827 other dead birds
with WNV infection were reported from 34 states, New York
City, and the District of Columbia (Figure 1); 87 WNV
infections in horses have been reported from 12 states
(Alabama, Florida, Georgia, Illinois, Kentucky, Louisiana,
Minnesota, Mississippi, North Dakota, South Dakota, Ten-
nessee, and Texas). During 2002, WNV seroconversions have
been reported in 52 sentinel chicken flocks from Florida,
Nebraska, and Pennsylvania; and 425 WNV-positive mos-
quito pools have been reported from 12 states (Alabama, Geor-
gia, Illinois, Indiana, Massachusetts, Mississippi, New Jersey,
Ohio, Pennsylvania, South Dakota, Texas, and Virginia), New
York City, and the District of Columbia.
West Nile Virus Activity — United States, July 31–August 7, 2002,
and Louisiana, January 1–August 7, 2002
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Recent human WNV infection and animal WNV activity
Animal WNV activity only
District ofColumbia
* As of August 7, 2002.
FIGURE 1. Areas reporting West Nile virus (WNV) activity —
United States, 2002*
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